Global Antibiotic R&D Partnership (GARDP)
Gabrielle KORNMANN is a seasoned professional in pharmacovigilance and drug safety, currently serving as the Drug Safety and Pharmacovigilance Leader at the Global Antibiotic R&D Partnership (GARDP) since September 2020. Previously, KORNMANN held various key positions at GeNeuro SA, including Pharmacovigilance Director and Medical Affairs and Alliance Director, from January 2015 to July 2020. A temporary role as a Pharmacist at HUG - Hôpitaux Universitaires de Genève involved preparing and reporting individual case safety reports to Swissmedic. Prior experiences include a sailing trip coupled with part-time teaching and a position as Senior Safety Scientist at United BioSource Corporation. KORNMANN's extensive career in the pharmaceutical industry also includes over a decade at Merck Serono, where leadership roles in medical safety evaluation were held, as well as a foundational period as a Clinical Data Analyst at the University of Geneva alongside a PhD in Pharmacology. KORNMANN earned a Federal Pharmacy Diploma in Pharmacy from the University of Geneva.
This person is not in the org chart
Global Antibiotic R&D Partnership (GARDP)
The Global Antibiotic Research & Development Partnership (GARDP) is a not-for-profit organization that develops new antibiotic treatments for drug-resistant bacterial infections that pose the greatest threat to human health, and makes them accessible to the people who need them. It puts public health needs at the centre of antibiotic drug development to address both the immediate antimicrobial resistance (AMR) crisis and to ensure people continue to get access to essential antibiotics for generations to come. GARDP works through a global network including Brazil, India, Japan, and South Africa for antibiotic development and access. Its work is made possible by essential funding from donors and collaboration with over 100 R&D and access partners in over 20 countries. GARDP was created by the World Health Organization and the Drugs for Neglected Diseases initiative (DNDi) in 2016 and legally registered as the GARDP Foundation in Geneva, Switzerland in 2018. www.gardp.org